+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2026-2032- Product Image
In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4905019
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Fertilization Market is projected to reach USD 14.78 Billion in 2026. It is expected to continue growing at a CAGR of 10.81%, reaching USD 27.49 Billion by 2032.

Infertility has become a mainstream public-health and demographic issue. The World Health Organization estimates that approximately 1 in 6 adults experience infertility during their lifetime, supporting sustained demand for in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), fertility preservation, donor gametes, and preimplantation genetic testing where legally permitted.

Since the first IVF birth in 1978, assisted reproductive technology has resulted in more than 10 million births worldwide, according to estimates widely cited by ESHRE and ICMART. Demand is being shaped by delayed parenthood, rising maternal age, male-factor infertility, oncology-related fertility preservation, LGBTQ+ family-building pathways, and broader acceptance of reproductive medicine.

For industry leaders, IVF success increasingly depends on evidence-based outcomes, affordability, laboratory standardization, regulatory trust, and patient experience. Competitive advantage is shifting toward transparent success-rate reporting, digitally enabled care, secure reproductive health data systems, and scalable embryology operations that maintain quality across multiple sites.

Transformative Shifts in the IVF Landscape

The IVF landscape is shifting from fragmented independent clinics toward integrated fertility networks, hospital-affiliated reproductive centers, and platform-based service models. Consolidation is enabling standardized protocols, centralized procurement, stronger data infrastructure, and more consistent laboratory quality management.

Clinical demand is also changing. Patients are older on average in many developed markets, increasing the need for individualized ovarian stimulation, oocyte vitrification, advanced embryo assessment, fertility preservation, and genetic counseling. In emerging markets, awareness and private healthcare investment are expanding access to assisted reproductive technology, although affordability remains a major barrier.

Policy is a decisive growth factor. Countries with public funding or insurance coverage typically see broader access and higher utilization, while self-pay markets rely more heavily on premium services, financing, package pricing, and cross-border reproductive care. The strongest operators are aligning clinical quality with access models that reduce patient drop-off and improve continuity of care.

Cumulative Impact of Artificial Intelligence on IVF

Artificial intelligence is becoming a practical decision-support layer across the IVF value chain. In embryology, AI-assisted image analysis and time-lapse monitoring are being used to support embryo grading, blastocyst assessment, and workflow consistency. In andrology, computer vision tools are being evaluated for semen analysis and sperm-selection standardization.

The most measurable near-term impact is operational rather than fully autonomous clinical decision-making. AI can reduce inter-observer variability, flag laboratory anomalies, optimize scheduling, improve medication adherence, and personalize patient communication, especially in high-volume fertility networks.

Adoption must remain evidence-led. IVF algorithms require external validation across diverse patient populations, transparent performance reporting, bias testing, cybersecurity safeguards, and compliance with health-data and medical-device regulations. Clinics that use AI under physician and embryologist oversight are best positioned to build trust and measurable value in assisted reproductive technology.

Key Regional Insights for IVF

Asia-Pacific is one of the most dynamic IVF regions because of large reproductive-age populations, delayed marriage, urbanization, declining fertility rates in several economies, and rising awareness of assisted reproductive technology. China, India, Japan, South Korea, and Australia anchor demand, while affordability, regulation, and clinic quality vary widely. Japan’s expanded fertility insurance coverage and India’s growing private fertility networks show two distinct pathways: public access expansion and private-sector scale.

North America remains a high-value IVF region led by the United States and Canada. The United States benefits from advanced embryology, broad use of ICSI and preimplantation genetic testing, employer fertility benefits, and strong patient willingness to pay, but access remains uneven because insurance mandates vary by state. Canada has strong clinical standards and selective provincial funding, although eligibility rules and wait times influence treatment utilization.

Europe combines mature clinical expertise with significant regulatory diversity. The United Kingdom, Germany, France, Italy, and Spain have established fertility ecosystems, but reimbursement, donor rules, embryo testing restrictions, cryostorage requirements, and age limits differ materially. Spain remains a leading destination for cross-border reproductive care because of donor-program capacity, specialized clinic infrastructure, and permissive rules for selected treatment pathways.

Latin America is gaining momentum, with Brazil and Mexico serving as important hubs for private fertility care and medical travel. The Middle East is expanding through GCC investment in women’s health, premium hospitals, and medical tourism, while religious and legal frameworks strongly influence treatment options. Africa remains underpenetrated despite a substantial infertility burden, with access constrained by cost, infrastructure, stigma, limited specialist availability, and uneven distribution of embryology laboratories.

Key Group Insights for IVF

ASEAN markets are benefiting from medical tourism, expanding private hospital groups, and growing awareness of infertility treatment, especially in Thailand, Singapore, Malaysia, Vietnam, and Indonesia. Growth is strongest where fertility regulation, laboratory accreditation, international patient services, and clinician training pathways are clearly established.

The GCC is investing in advanced healthcare infrastructure, women’s health services, and specialist reproductive medicine. Cultural, religious, and legal frameworks shape IVF pathways, particularly around donor gametes, embryo handling, genetic testing, and surrogacy, making localized compliance essential for fertility clinic operators, laboratory suppliers, and reproductive technology vendors.

The European Union provides a sophisticated but highly regulated IVF environment. GDPR governs reproductive health data, while medical-device, tissue-handling, laboratory, and clinical governance requirements influence AI tools, culture media, genetic testing, cryostorage systems, and digital patient platforms. BRICS countries represent long-term scale, with China, India, and Brazil especially important, although affordability, infrastructure quality, and regulatory oversight remain decisive.

G7 countries lead in clinical research, premium fertility technology, outcome reporting, and payer innovation, but face aging populations, delayed parenthood, and cost-access challenges. NATO is not a fertility-policy bloc; however, many member countries share advanced healthcare infrastructure, cybersecurity priorities, and military-family health considerations that can affect reproductive health service planning and fertility benefit design.

Key Country Insights for IVF

The United States is the world’s most commercially advanced IVF market, with extensive use of ICSI, preimplantation genetic testing, fertility financing, employer benefits, and multi-site clinic networks; CDC reporting shows assisted reproductive technology accounts for a small but meaningful share of U.S. births each year. Canada offers strong clinical governance, though provincial funding differences shape access. Mexico is growing as a cost-competitive destination for North American patients, while Brazil is Latin America’s largest fertility market by scale, specialist capacity, and private reproductive medicine infrastructure.

In Europe, the United Kingdom combines HFEA oversight with a sophisticated private market, although NHS funding varies by location. Germany has strict embryo-protection rules and selective reimbursement, while France expanded access to assisted reproduction for single women and female couples. Russia has historically had significant ART capacity, Italy operates within evolving legal constraints, and Spain is a major hub for donor-assisted IVF and cross-border reproductive care.

In Asia-Pacific, China represents major demand potential due to demographic pressure, delayed childbearing, and expanding reproductive medicine capacity. India is scaling through private fertility chains, value-oriented medical care, and growing awareness beyond major metropolitan centers. Japan has high treatment utilization linked to delayed childbearing and policy support, while South Korea combines advanced healthcare infrastructure with very low fertility rates. Australia is a mature, well-regulated IVF market with strong outcome reporting, public-private participation, and established fertility preservation services.

Actionable Recommendations for IVF Industry Leaders

Industry leaders should prioritize transparent, risk-adjusted outcome reporting because patients, payers, and regulators increasingly evaluate IVF providers on live-birth outcomes, safety, multiple-pregnancy reduction, and patient experience. Clinics should publish understandable success-rate metrics while avoiding misleading comparisons across age groups, infertility diagnoses, and treatment types.

Operational excellence in the embryology laboratory is essential. Leaders should invest in validated culture systems, quality management, temperature and air-quality monitoring, chain-of-custody safeguards, cryostorage risk controls, emergency preparedness, and continuous embryologist training. Standardized protocols are especially important for multi-site fertility networks.

Commercial strategy should focus on access and trust. Financing options, fertility benefits partnerships, employer programs, multilingual patient navigation, counseling support, and evidence-based digital engagement can reduce treatment drop-off. AI should be deployed only through validated use cases, with human oversight, bias testing, audit trails, cybersecurity controls, and clear patient communication embedded from the start.

Research Methodology

This executive summary is based on a structured review of public-health, regulatory, clinical, and industry indicators relevant to in-vitro fertilization. Core reference points include infertility prevalence estimates from the World Health Organization, ART reporting frameworks such as the CDC in the United States and HFEA in the United Kingdom, and reproductive medicine guidance from professional bodies including ESHRE and ASRM.

The analysis prioritizes verified signals, including demographic fertility trends, maternal-age patterns, reimbursement structures, regulatory rules, clinic-network expansion, cross-border reproductive care, laboratory technology adoption, quality management practices, and AI validation requirements. Regional, group, and country insights are synthesized from public sources and established industry patterns rather than unsupported projections.

Because IVF regulation and reimbursement can change quickly, findings should be interpreted as an executive-level industry view rather than legal or clinical advice. Market-entry, investment, and product-launch decisions should be supported by country-specific regulatory review, payer analysis, ethical assessment, and clinical expert validation.

Conclusion

In-vitro fertilization is entering a new phase defined by broader demand, higher clinical expectations, stronger regulation, and rapid technology adoption. Long-term fundamentals are supported by global infertility prevalence, delayed parenthood, declining birth rates in many economies, and growing acceptance of assisted reproduction.

The most successful organizations will combine medical credibility with operational scale. Clinics, laboratories, technology vendors, and investors that deliver evidence-based outcomes, accessible pricing, secure data systems, and patient-centered care will be best positioned to build sustainable leadership in IVF services.

AI, genetic testing, cryopreservation, and digital care platforms will continue to reshape IVF, but trust will remain the industry’s core asset. Sustainable leadership will depend on balancing innovation with ethical practice, regulatory compliance, and measurable improvements in live-birth outcomes and patient safety.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Fertilization Market, by Product
7.1. Culture Media
7.1.1. Cryopreservation Media
7.1.2. Embryo Culture Media
7.1.3. Ovum Processing Media
7.1.4. Sperm Processing Media
7.2. Disposable Devices & accessories
7.3. Equipment
7.3.1. Anti-vibration Tables
7.3.2. Cryosystems
7.3.3. Gas Analyzers
7.3.4. Imaging Systems
7.3.5. Incubators
7.3.6. IVF Cabinets
7.3.7. Laser Systems
7.3.8. Micromanipulator Systems
7.3.9. Microscopes
7.3.10. Ovum Aspiration Pumps
7.3.11. Sperm Analyzer Systems
7.3.12. Sperm Separation Devices
7.3.13. Witness Systems
8. In-Vitro Fertilization Market, by Embryo Source
8.1. Fresh Donor
8.2. Fresh Non-donor
8.3. Frozen Donor
8.4. Frozen Non-donor
9. In-Vitro Fertilization Market, by Procedure Type
9.1. Assisted Hatching
9.2. Conventional IVF
9.3. Frozen Embryo Transfer (FET)
9.4. Gamete Intrafallopian Transfer (GIFT)
9.5. Intracytoplasmic Sperm Injection (ICSI)
9.6. Zygote Intrafallopian Transfer (ZIFT)
10. In-Vitro Fertilization Market, by Application
10.1. Female Infertility
10.1.1. Endometriosis
10.1.2. Ovulatory Disorders
10.1.3. Tubal Factor Infertility
10.1.4. Unexplained Infertility
10.2. Male Infertility
10.2.1. Abnormal Sperm Morphology
10.2.2. Low Sperm Count
10.2.3. Poor Sperm Motility
11. In-Vitro Fertilization Market, by End User
11.1. Ambulatory Surgery Centers
11.2. Fertility Clinics
11.3. Hospitals
12. Asia-Pacific In-Vitro Fertilization Market
13. North America In-Vitro Fertilization Market
14. Latin America In-Vitro Fertilization Market
15. Europe In-Vitro Fertilization Market
16. Middle East In-Vitro Fertilization Market
17. Africa In-Vitro Fertilization Market
18. ASEAN In-Vitro Fertilization Market
19. GCC In-Vitro Fertilization Market
20. European Union In-Vitro Fertilization Market
21. BRICS In-Vitro Fertilization Market
22. G7 In-Vitro Fertilization Market
23. NATO In-Vitro Fertilization Market
24. United States In-Vitro Fertilization Market
25. China In-Vitro Fertilization Market
26. Germany In-Vitro Fertilization Market
27. Japan In-Vitro Fertilization Market
28. India In-Vitro Fertilization Market
29. United Kingdom In-Vitro Fertilization Market
30. Canada In-Vitro Fertilization Market
31. Russia In-Vitro Fertilization Market
32. Brazil In-Vitro Fertilization Market
33. Italy In-Vitro Fertilization Market
34. Mexico In-Vitro Fertilization Market
35. France In-Vitro Fertilization Market
36. Spain In-Vitro Fertilization Market
37. Australia In-Vitro Fertilization Market
38. South Korea In-Vitro Fertilization Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. Carl Zeiss AG
40.2. Cook Medical Inc.
40.3. CooperSurgical Inc.
40.4. Corning incorporated
40.5. Esco micro pte. Ltd.
40.6. Ferring B.V.
40.7. FertiPro N.V.
40.8. Genea Biomedx Pty Ltd.
40.9. Hamilton Thorne, Inc.
40.10. INVO Bioscience, Inc.
40.11. IVFtech ApS
40.12. Kitazato Corporation
40.13. Laboratoire CCD
40.14. Meiji Techno Co., Ltd.
40.15. Merck KGaA
40.16. Nidacon International AB
40.17. Nikon Corporation
40.18. Olympus Corporation
40.19. Thermo Fisher Scientific Inc.
40.20. Vitrolife AB
List of Figures
FIGURE 1. GLOBAL IN-VITRO FERTILIZATION MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO FERTILIZATION MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IN-VITRO FERTILIZATION MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IN-VITRO FERTILIZATION MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CHINA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. INDIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. CANADA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. ITALY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN-VITRO FERTILIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CRYOSYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CRYOSYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CRYOSYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GAS ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GAS ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GAS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IVF CABINETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IVF CABINETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IVF CABINETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LASER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LASER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LASER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MICROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MICROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MICROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FROZEN DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FROZEN DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FROZEN DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ASSISTED HATCHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ASSISTED HATCHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ASSISTED HATCHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL LOW SPERM COUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL LOW SPERM COUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL LOW SPERM COUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 171. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 172. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 173. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 177. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 191. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 192. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 193. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 194. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 195. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 198. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 201. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 202. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 203. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 207. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 211. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 212. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 213. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 214. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 215. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 217. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 218. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 230. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 231. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 232. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 233. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 234. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 235. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 236. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 237. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 238. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 241. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 242. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 243. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 244. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 245. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 247. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 248. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 250. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 251. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 252. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 253. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 254. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 255. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 257. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 258. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. CHINA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 271. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 272. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 273. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 274. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 275. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 277. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 278. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 281. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 282. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 283. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 284. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 285. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 287. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 288. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 290. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 291. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 292. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 293. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 294. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 295. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 296. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 297. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 298. JAPAN IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. INDIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 300. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 301. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 302. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 303. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 304. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 305. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 306. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 307. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 308. INDIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 319. CANADA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 321. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 322. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 323. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 324. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 325. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 326. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 327. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 328. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 329. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 330. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 331. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 332. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 333. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 334. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 335. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 336. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 337. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 338. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 339. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 340. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 341. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 342. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 343. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 344. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 345. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 346. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 347. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 348. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 349. ITALY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 350. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 351. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
TABLE 352. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 353. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
TABLE 354. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 355. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 356. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 357. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
TABLE 358. ITALY IN-VITRO FERTILIZATION MARK

Companies Mentioned

The companies featured in this In-Vitro Fertilization market report include:
  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Esco micro pte. Ltd.
  • Ferring B.V.
  • FertiPro N.V.
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Meiji Techno Co., Ltd.
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB

Table Information

Report AttributeDetails
No. of Pages191
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 14.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 27.49 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

In-Vitro Fertilization Devices & Supplies Market by Product Type, Procedure Type, Technology, End User, Patient Type, Distribution Channel - Global Forecast 2026-2032 - Product Image

In-Vitro Fertilization Devices & Supplies Market by Product Type, Procedure Type, Technology, End User, Patient Type, Distribution Channel - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
In-vitro Fertilization Microscopes Market - Global Forecast 2026-2032 - Product Image

In-vitro Fertilization Microscopes Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
In Vitro Fertilization Banking Services Market Report and Forecast 2025-2034 - Product Image

In Vitro Fertilization Banking Services Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Donor Egg in Vitro Fertilization (IVF) Services Market Report 2026 - Product Image

Donor Egg in Vitro Fertilization (IVF) Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cryopreservation for In-Vitro Fertilization (IVF) Market Report and Forecast 2025-2034 - Product Image

Cryopreservation for In-Vitro Fertilization (IVF) Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the In Vitro Fertilization Market

In Vitro Fertilization (IVF) is a medical procedure used to assist women in achieving pregnancy. It involves the fertilization of an egg outside of the body, in a laboratory setting. The egg is then transferred to the uterus, where it can implant and develop into a fetus. IVF is often used when other fertility treatments have failed, or when a woman has difficulty conceiving due to age, medical conditions, or other factors. It is also used for couples who are unable to conceive naturally due to male infertility. IVF has become an increasingly popular option for women seeking to become pregnant. It is a safe and effective procedure, with a high success rate. It is also a cost-effective option, as it can be used multiple times until a successful pregnancy is achieved. Some of the companies in the IVF market include OvaScience, CooperSurgical, and Ferring Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.